Companies: 10,795·Total market cap: $144.5T
CSL Limited

CSL Limited

CSLLYOTCHealthcare● Active
$17.12
+$0.00(+0.00%)
Market Cap$66.3B
P/E Ratio—
52W High$44.855
52W Low$16.29
Cash on HandFinancialsRevenue

CSL Limited (CSLLY) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CSLLY · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$2.16B▲ +30.2% vs prior year
FY · as of Jun 30, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$2.16B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+30.2%
vs prior fiscal year
Latest Quarter
$1.15B
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$2.16BCash on Hand
Total Debt$11.50BTotal Debt
Net Cash / Net Debt−$9.34BNet Debt Position
Cash vs Debt Ratio
Cash 16%Debt 84%

CSL Limited carries a net debt position of $9.34B. Total debt ($11.50B) exceeds cash on hand ($2.16B). CSL Limited cash vs debt ratio: 16% cash / 84% debt.

Net Cash = Cash & ST Investments − Total Debt$2.16B − $11.50B = −$9.34B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CSLLY annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$2.16B+30.2%
Jun 30, 2024$1.66B+7.0%
Jun 30, 2023$1.55B-85.2%
Jun 30, 2022$10.44B+668.5%
Jun 30, 2021$1.36B+64.1%
CSLLY cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
CSL Limited
CSL LimitedYOU
CSLLY
$2.16B3.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

CSL Limited (CSLLY) cash on hand as of June 30, 2025 is $2.16B, comprising $2.16B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as CSL Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as CSL Limited cash reserves or cash position.

CSL Limited annual cash on hand history shows increased +30.2% in 2025: increased +30.2% in 2025. CSL Limited cash reserves in 2025 reflect the company's capital allocation strategy.

CSL Limited carries total debt of $11.50B against cash of $2.16B, resulting in a net debt position of -$9.34B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

CSLLY cash on hand · 5 questions

As of June 30, 2025, CSL Limited (CSLLY) has $2.16B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2.16B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $1.15B. Data sourced from the annual 10-K filing via FMP.

CSLLY cash on handCSLLY cash reservesCSLLY cash 2025how much cash does CSLLY have

▸ Source: FMP /balance-sheet-statement · US GAAP · CSL Limited · CSL Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025